ARISGLOBAL INTRODUCES inforMED 1.2, A COMPLETE WEB-BASED MEDICAL INFORMATION SOLUTION
ArisGlobal, the leading provider of software solutions for the pharmaceutical, biotechnology and medical device industries, has introduced inforMED™ 1.2, a comprehensive, Web-based medical information system that allows organizations to quickly and effectively handle, route and respond to inquiries from consumers and healthcare practitioners alike.
inforMED gives life science organizations the ability to address heavy volumes of inquiries from patients, physicians, investigators and field staff, which can often be driven by events like new product introductions, labeling changes or an increase in self-medication and off-label usage. With inforMED, medical information departments can deliver the right answer to the right person at the right time, helping improve patient safety, optimize information flow and address product concerns in a proactive manner.
Medical communication specialists can use inforMED to build up a library of answers to frequently asked questions, which can be used as pre-approved and consistent responses to inquiries based on the most current medical knowledge. inforMED enables full-text searches within subscription publication databases such as Medline, Biosys and Embase, as well as company sources, attaching journal articles and/or citations as needed. Multiple questions can be handled per inquiry, with approved responses distributed automatically by email or fax. Standard templates are auto-populated with variable data such as an inquirer’s name, title, address and question details.
New features and functions of inforMED 1.2 include the ability to perform copyright tracking of documents used in formulating responses, to avoid infringement issues and facilitate royalty payments; seamless integration with Business Objects™ for report generation and distribution, as well as an increase in standard report templates; and streamlined FAQ usage.
Since medical information departments are often the first point of contact for inquiries that turn out to be adverse event reports, product complaints or safety issues, inforMED includes additional fields to assist with the necessary information-gathering. These inquiries can then be easily re-directed to ARISg, ArisGlobal’s drug safety and pharmacovigilance software solution, or to other third-party products, to ensure proper reporting, authority notification and regulatory compliance. Thus, inforMED is an ideal issue triage center for the life science enterprise.
When a question requires a new response, this usually involves escalation, authoring and peer review. The query can be routed through inforMED to the appropriate experts for research, authoring, review and approval before being automatically sent to the inquirer. This allows companies to achieve significant improvements in turnaround times for custom or complex responses, while allowing near-instant response for previously researched questions.
All inquiry activity handled within inforMED includes the capture of operator identification as well as time and date stamps, creating an electronic audit trail for 21 CFR Part 11 and Annex 11 compliance. The ability to quickly and easily access the latest standard medical literature via inforMED helps ensure compliance with European regulations like Title IX, and regulations or guidelines which may arise from ICH E2D.
With its intuitive, configurable Web user interface, inforMED enables easy operator entry and prioritization of inquiries, with an inbox that uses a color-coded system. It is built on standard J2EE architecture, using XML as its data transfer format and an Oracle database for storage.
“By creating an informed consumer who will demand new medicinal products, the industry has simultaneously created a consumer who expects to be continually and accurately informed throughout their use of those products,” said Mark Loudon, director of regulatory compliance at ArisGlobal. “This new army of consumers is also an army of information consumers, and inforMED is the ideal tool to deal with the upsurge in demand for medical information.”
About ArisGlobal
Since 1985, ArisGlobal has been the leading provider of integrated software solutions and services to pharmaceutical ArisGlobal is the leading provider of risk management and compliance software solutions to the pharmaceutical, biotechnology, life science, medical device and clinical research organization (CRO) markets. With over 15 years of industry experience, ArisGlobal counts 9 of the top 15 pharmaceutical providers and 5 of the top 10 biotechnology firms among its clients. ArisGlobal software helps companies meet international regulatory requirements, track clinical trial data, manage risk, improve operational efficiencies and easily share mission-critical information on a global basis. For more information on ArisGlobal, visit www.arisglobal.com
